This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
1 Aug 2013

Funding granted for DMD therapy development

The UK Biomedical Catalyst Fund has granted £2.4 million funding for the development of DMD treatment.

 

Funding has been granted for the development of therapies and drugs for Duchenne Muscular Dystrophy (DMD) to the UK company Summit.

Related News